학술논문
Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm2 : A Phase 1 Maximal-Use Trial in Patients with Actinic Keratosis
Document Type
Article
Author
Source
In: Clinical Pharmacology in Drug Development . (Clinical Pharmacology in Drug Development, February 2024, 13(2):208-218)
Subject
Language
English
ISSN
21607648
2160763X
2160763X